|
Real-time Estimate
Cboe BZX
03:40:23 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 72.48 USD | -1.23% |
|
-0.25% | +10.87% |
| 06/10 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 21/09 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.23% | -0.25% | -9.50% | -32.60% | +10.87% | -13.97% | +3,484.16% | +201.67% | - | 493M | |
| +0.34% | -3.03% | -11.69% | +16.15% | +57.65% | +37.45% | +61.06% | +6.44% | - | 64.14B | |
| +0.98% | +2.68% | -5.19% | +3.71% | +12.22% | +12.25% | +83.90% | +210.70% | +5,645.71% | 55.53B | |
| +1.48% | +1.72% | +9.42% | +11.17% | +18.82% | +12.98% | +105.14% | -14.87% | +242.08% | 53.03B | |
| -0.54% | -0.24% | +3.22% | +12.16% | +23.18% | +27.46% | +56.73% | +6.21% | +287.03% | 45.99B | |
| -0.44% | -2.74% | +1.78% | +13.62% | +22.37% | +18.08% | +99.23% | +3.93% | +1,018.47% | 42.45B | |
| +0.26% | +1.11% | -7.19% | +4.90% | +138.27% | +227.09% | +934.22% | +544.85% | - | 40.45B | |
| -0.26% | -4.20% | +6.17% | +6.71% | +9.81% | +10.86% | +45.18% | +6.84% | +157.79% | 32.25B | |
| -2.07% | +42.73% | +63.49% | +102.89% | +86.88% | +103.77% | +90.26% | +31.35% | +238.82% | 34.47B | |
| -2.72% | -8.79% | -15.62% | +16.80% | +43.32% | +22.58% | -5.63% | -60.89% | - | 24.23B | |
| +0.34% | -1.26% | -10.18% | -4.74% | -7.00% | -14.33% | -5.05% | -68.23% | - | 22.1B | |
| +14.02% | +17.52% | -3.39% | +8.33% | -35.81% | -33.08% | +369.39% | +270.53% | +760.67% | 21.18B | |
| -1.14% | +5.06% | +10.44% | +17.46% | +22.33% | +17.53% | +184.15% | +203.28% | +2,267.57% | 19.38B | |
| +1.03% | +11.36% | +27.81% | +61.10% | +89.62% | +109.97% | +129.92% | -15.69% | +398.50% | 17.85B | |
| +0.97% | +4.59% | +14.28% | +26.86% | +39.55% | +43.70% | +86.35% | -14.58% | +110.39% | 16.69B | |
| -1.12% | +0.33% | +11.72% | +18.43% | +49.50% | +66.18% | +223.74% | +204.63% | +518.74% | 16.42B | |
| +0.68% | +3.65% | +10.43% | -0.08% | - | - | - | - | - | 16.39B | |
| +3.33% | +5.53% | +7.36% | +11.21% | +192.66% | +175.10% | +360.46% | +1,478.53% | +825.12% | 15.33B | |
| +1.39% | +16.48% | +26.79% | +21.22% | +18.53% | +30.15% | -9.30% | -24.68% | +169.04% | 16.04B | |
| +0.97% | -7.48% | -3.82% | -13.90% | +11.63% | +3.79% | +468.94% | - | - | 13.21B | |
| Average | +0.82% | +3.74% | +6.32% | +15.07% | +42.34% | +45.13% | +355.94% | +165.00% | +972.30% | 28.38B | |
| Weighted average by Cap. | +0.65% | +3.36% | +5.10% | +17.45% | +42.35% | +46.76% | +172.69% | +124.53% | +1,264.74% |
- Stock Market
- Stocks
- MNPR Stock
- Sector Monopar Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
